Construction method of self-organized woven bone-like organ, self-organized woven bone-like organ and bone repair application of self-organized woven bone-like organ
By constructing self-organized braided bone organoids, using CGDE dual network functional hydrogels and bone cells to induce differentiation in vitro, the problem of inability to heal bone defects and the risk of traditional bone transplantation is solved, bone regeneration and integration are achieved, and bones are improved Repair effect.
Patent Information
- Application Number
- CN202411177706.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-29
AI Technical Summary
Bone defects cannot heal themselves in some cases. Traditional bone transplantation has risks and limitations, and the prior art is difficult to effectively promote the regeneration and repair of bone tissue.
Self-organized braided bone organoids were constructed through bionic strategies, and CGDE dual network functional hydrogels and bone cells were used to induce differentiation in vitro to form braided bone organoids with multi-layered structures and osteogenic activity for bone defect repair.
It realizes the formation of mature lamellar bones in the body, quickly connects defect breaks, promotes bone regeneration and integration, and improves the functionality and durability of bone repair.
Smart Images

Figure CN119040254A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of organoids, and in particular relates to a method for constructing a self-organizing woven bone organoid, a self-organizing woven bone organoid and a bone repair application thereof. Background Art
[0002] Bone defects are a common problem in orthopedic trauma surgery. Under normal circumstances, bone tissue has a certain ability to repair and reconstruct itself, but when the length of the bone defect exceeds a certain range, the bone tissue cannot completely heal itself, forming a critical bone defect. Therefore, bone transplantation is generally regarded as the preferred method for treating bone defects. More than 4 million patients in China require bone transplantation surgery each year, including autologous, allogeneic or xenogeneic bone transplantation. However, bone transplantation is also accompanied by some risks, such as secondary trauma, limited transplant sources, immune rejection, and the risk of disease transmission.
[0003] Bone tissue engineering is an emerging method for solving the problems existing in traditional bone transplantation. It uses a combination of biomaterials, cells and biological factors to simulate the structure and function of natural bone tissue, thereby promoting the regeneration and healing of damaged parts. The main goal of bone tissue engineering is to develop treatments that replace traditional bone transplantation to solve problems such as limited transplant sources, immune rejection and secondary trauma. By combining biomaterials and cells, artificial bone tissue with good biocompatibility and activity is created, providing a new way to repair bone damage.
[0004] Relying on the development of bone tissue engineering technology, bone organoids came into being. Organoid technology is used to culture more miniature bone tissue structures in vitro for the treatment of bone injuries and diseases. Bone organoids are micro-bone tissues cultured in the laboratory that can simulate the structure and function of bones. It uses the self-organizing properties of mammalian pluripotent stem cells or stem cells derived from adult tissues to construct a three-dimensional microenvironment similar to that in vivo in vitro, thereby forming organoids with multiple cell types. Compared with traditional two-dimensional cell culture, organoids are richer in tissue structure. Bone organoids can be designed into complex structures similar to natural bone tissue, including multi-level microstructures and macroscopic morphologies, thereby improving the functionality and durability of the repaired area.
[0005] In the process of bone repair, woven bone is the main bone tissue form in the bony healing period, which is obtained by the mineralization of fibrous callus. In the final stage of bone remodeling, woven bone is slowly replaced by lamellar bone to achieve bone repair. Woven bone has a multi-layered structure, including thick collagen fibers and diverse cellular components. Early woven bone is rich in mesenchymal stem cells and cytokines, which can effectively promote the osteogenic differentiation and mineralization of tissues, and contribute to the repair and regeneration of bone tissue. Therefore, using woven bone as a prototype, through three-dimensional induced culture, in vitro biomimetic construction of woven bone organoids will provide a reference for the construction of a successful pathological model of bone tissue, and will also be beneficial to bone regeneration and repair after implantation of defective bone tissue. Summary of the invention
[0006] The present invention provides a method for constructing a self-organizing woven bone organoid and its application. The method for constructing a woven bone organoid is biomimetically designed based on the structural components and functional activity of woven bone. By effectively regulating the induced differentiation of seed cells, the cells are promoted to self-organize to form a woven bone organoid with a spatial characteristic structure. A biomimetic matrix material is prepared based on the structure and components of woven bone to provide structural support and component support for the three-dimensional growth of cells. Through adaptive cultivation for a certain period of time, the proliferation and growth of cells in the matrix material are promoted, and the cell activity in the organoid is improved. Finally, under the regulation of osteogenic induction factors, the cells are induced to differentiate under the action of biochemical factors and physical stimulation, self-organize to form an intercellular osteogenic mineralization communication network, secrete extracellular matrix, and construct a woven bone organoid. The constructed self-organizing woven bone organoid has suitable mechanical properties, biomimetic microstructures, good osteogenic, anti-inflammatory, and tubular functional activities, can form bone tissue after reconstruction in vivo, and is used for repairing bone defects.
[0007] In one aspect, the present application provides a method for constructing a self-organizing woven bone organoid, comprising the following steps: S1: Prepare CGDE double network functional hydrogel, a matrix material for woven bone organoids, or provide other organoid growth matrices.
[0008] S2: Provide woven bone organoid seed cells and culture and expand them in large quantities using complete culture medium S3: Prepare woven bone organoid matrix material, preheat the hydrogel obtained in S1 at 37°C to make it completely solubilized, use the preheated hydrogel solution to resuspend the cells obtained in S2, mix thoroughly, inject into the mold and irradiate under a 405nm light source for 10-60s to make it gel for subsequent culture.
[0009] S4: Adaptive culture of woven bone organoids. Soak the sample obtained in S3 in basal culture medium and place it in a 37°C incubator for 5 minutes. Wash the sample and then use complete culture medium to adaptively culture the organoids for 1-7 days. During the culture period, use fresh culture medium every 2-3 days.
[0010] S5: Osteogenic differentiation of woven bone organoids. The samples obtained in S4 were transferred to osteogenic induction medium for osteogenic induction for 7-40 days. Fresh medium was replaced every 2-3 days during the culture period to prepare woven bone organoids at different developmental stages.
[0011] Preferably, the woven bone organoid matrix material described in S1 is a CGDE double network functional hydrogel, which is formed by a complex of catalase (CAT), GelMa, energy active calcium phosphate (EACP), and DNA, and the preparation method is as follows: S11: Prepare CAT solution by dissolving 100-400 mg CAT, 10-50 mg AC-PEG-NHS crosslinker, and 10-100 mg LAP photoinitiator in 20 mL PBS. Vortex for 5 minutes in the dark, filter through a 0.22 μm filter membrane to sterilize, and incubate at 4 °C in the dark for 18-24 h.
[0012] S12: Prepare GelMa solution by soaking 1 g of GelMa in 5-20 mL of PBS, heating and dissolving at 60-70°C for 0.5-2 hours, filtering and sterilizing with a 0.22 μm filter membrane to prepare GelMa solution, and storing at -20°C.
[0013] S13: To prepare EACP nanoparticles, add 25 mL of an aqueous solution containing 1-5 g Na2ATP to 900 mL of pure water, then add 20 mL of an aqueous solution containing 0.5-3 g CaCl2, mix thoroughly, adjust the pH to 8.0-8.5 with 0.2 M NaOH, then add 1.6 mL of an aqueous solution containing 1.5-6 mg ALP and react for 2-6 hours, with the pH maintained at 8.0-8.5 during the reaction. After the reaction, centrifuge to obtain EACP nanoparticles, wash the precipitate with pure water 2-3 times, then soak in anhydrous ethanol, and store at -20°C.
[0014] S14: Prepare a DNA mixed solution. Add DEPC water to Y-1, Y-2, Y-3, L-1, and L-2, vortex and dissolve to prepare a 50-200 μM DNA solution. Mix Y-1, Y-2, and Y-3 in equal proportions to prepare a Y-DNA mixed solution. Mix L-1 and L-2 in equal proportions to prepare an L-DNA mixed solution. Store at -20°C.
[0015] S15: Mix the CAT solution obtained in S11 and the GelMa solution obtained in S12 in a mass ratio of 1:1, add the EACP obtained in S13, the Y-DNA mixed solution obtained in S14 and the L-DNA mixed solution, vortex mix thoroughly to prepare a hydrogel precursor solution, and store it at -20°C away from light.
[0016] Preferably, the seed cell types described in S2 include bone cell lineages such as BMSC, MC3T3-E1, PDCs, and Osteoblast.
[0017] Preferably, in the woven bone organoid bio-ink described in S3, the ratio of matrix material solution to cells is 1*10 4 ~1*10 9 cells.
[0018] Preferably, the complete medium for organoid adaptive culture described in S4 is prepared by adding 50 mL FBS and 5 mL PS to 500 mL basal medium. The basal medium used includes but is not limited to α, DMEM, and DMEM / F-12.
[0019] Preferably, the preparation method of the osteogenic differentiation medium in S5 is to add 50 mL FBS, 5 mL PS, 5 mL 1 M β-GP, 1.25 mL 20 mg / mL Vitamin C, and 50 μL 100 μM DXMS into 500 mL DMEM medium).
[0020] On the other hand, the present application also provides a self-organizing woven bone organoid, characterized in that it is prepared by any one of the above-mentioned methods for constructing a self-organizing woven bone organoid.
[0021] On the other hand, the present application also provides a use of the above-mentioned construction method or the above-mentioned self-organized woven bone organoid in preparing a bone physiological and pathological model and a bone regeneration and repair material.
[0022] Preferably, the application is to use the woven bone organoid as an implant, transplant it into the bone defect site, and after reconstruction, effectively integrate it with the bone tissue to achieve bone regeneration and repair.
[0023] Beneficial effects: The present invention adopts a bionic strategy to prepare a woven bone organoid for bone defect repair. The main characteristics of the woven bone organoid are that the number of cells in the woven bone organoid is large and the differentiation activity is high. At the same time, there are osteoblast lineages at different developmental stages, and the cells can self-organize to form a network structure, produce extracellular matrix through autocrine secretion, and have autonomous mineralization ability. When used for bone defect repair, it can be remodeled in vivo to form mature lamellar bone, and achieve bone integration with native bone tissue, effectively promoting bone regeneration at the defect site. On the one hand, the cell network in the woven bone organoid can quickly connect the defect segment and quickly promote bone integration through the osteogenic activity of the cells themselves; on the other hand, the mineralized matrix secreted by the woven bone organoid fuses with the matrix material to synergistically provide structural support for the defect site. As new bone is generated, the matrix material gradually degrades and releases mineral ions, promoting the growth and development of bone tissue. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.
[0025] Figure 1 A physical picture of the self-organizing woven bone organoid and a bright field image of the microscopic cell morphology in the organoid tissue in the present invention; Figure 2 It is a three-dimensional live-dead staining and three-dimensional cytoskeleton staining image of cells in the tissue after the construction of the self-organizing woven bone organoid in the present invention; Figure 3 These are Micro-CT three-dimensional reconstruction images of the self-organizing woven bone organoids in the present invention and scanning images of the sagittal and horizontal planes of the woven bone organoids.
[0026] Figure 4 H&E staining and Masson staining images of paraffin sections of the self-organizing woven bone organoids in the present invention; Figure 5 The images are Alizarin red (ARS) staining images of paraffin sections of the self-organizing woven bone organoids and the immunohistochemical images of Col-1; Figure 6 OCN immunohistochemical staining images of paraffin sections of self-organizing woven bone organoids in the present invention and double immunofluorescence staining images of OSX and PDPN; Figure 7 Micro-CT three-dimensional reconstruction and sagittal scanning imaging of new bone formation at the bone defect site after the self-organized woven bone organoids in the present invention were used to repair the skull defect of SD rats; Figure 8The present invention is a flow chart of the steps of the preparation method. DETAILED DESCRIPTION
[0027] The following will be combined with the drawings in the embodiments of the present application to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.
[0028] In conjunction with the accompanying drawings, some embodiments of the present application are described in detail below. In the absence of conflict, the following embodiments and features in the embodiments can be combined with each other.
[0029] Embodiment 1: Reference Figures 1 to 6 This embodiment provides a method for constructing a self-organizing woven bone organoid, based on the prepared CGDE double network functional hydrogel, a large number of expanded BMSCs are resuspended in a hydrogel solution, and after light curing, adaptive culture is performed for 1 to 3 days and osteogenic induction differentiation is performed for 21 days, comprising the following steps: S1: Preparation of CGDE double network functional hydrogel as matrix material for woven bone organoids; S2: Provide BMSCs, culture and expand them in large quantities using complete culture medium; S3: Prepare woven bone organoid matrix material. Preheat the hydrogel obtained in S1 at 37°C to make it completely solubilized. Use the preheated hydrogel solution to resuspend the cells obtained in S2. The ratio of matrix material to cells is 1 mL matrix material contains 1*10 4 ~1*10 9 After the obtained woven bone organoid precursor cell mixture is fully mixed, it is injected into a mold and irradiated under a 405nm light source for 10-60s to gel it for subsequent culture; S4: Adaptive culture of woven bone organoids: soak the sample obtained in S3 in basal culture medium, place it in a 37°C incubator for 5 minutes, wash the sample, and then switch to α-MEM for adaptive culture of the organoids for 1 to 3 days; S5: osteogenic differentiation of woven bone organoids. The samples obtained in S4 were transferred to osteogenic induction medium for osteogenic induction for 21 days. Fresh medium was replaced every 2-3 days during the culture period to prepare woven bone organoids with osteogenic differentiation for 21 days. In this embodiment, the preparation method of the CGDE double network functional hydrogel described in S1 is as follows: S11: Prepare CAT solution by dissolving 100-400 mg CAT, 10-50 mg AC-PEG-NHS crosslinker, and 10-100 mg LAP photoinitiator in 20 mL PBS. Vortex for 5 minutes in the dark, filter through a 0.22 μm filter membrane to sterilize, and incubate at 4 °C in the dark for 18-24 h.
[0030] S12: Prepare GelMa solution by soaking 1 g of GelMa in 5-20 mL of PBS, heating and dissolving at 60-70°C for 0.5-2 hours, filtering and sterilizing with a 0.22 μm filter membrane to prepare GelMa solution, and storing at -20°C.
[0031] S13: To prepare EACP nanoparticles, add 25 mL of an aqueous solution containing 1-5 g Na2ATP to 900 mL of pure water, then add 20 mL of an aqueous solution containing 0.5-3 g CaCl2, mix thoroughly, adjust the pH to 8.0-8.5 with 0.2 M NaOH, then add 1.6 mL of an aqueous solution containing 1.5-6 mg ALP and react for 2-6 hours, with the pH maintained at 8.0-8.5 during the reaction. After the reaction, centrifuge to obtain EACP nanoparticles, wash the precipitate with pure water 2-3 times, then soak in anhydrous ethanol, and store at -20°C.
[0032] S14: Prepare a DNA mixed solution. Add DEPC water to Y-1, Y-2, Y-3, L-1, and L-2, vortex and dissolve to prepare a 50-200 μM DNA solution. Mix Y-1, Y-2, and Y-3 in equal proportions to prepare a Y-DNA mixed solution. Mix L-1 and L-2 in equal proportions to prepare an L-DNA mixed solution. Store at -20°C.
[0033] S15: Mix the CAT solution obtained in S11 and the GelMa solution obtained in S12 in a mass ratio of 1:1, add the EACP obtained in S13, the Y-DNA mixed solution obtained in S14 and the L-DNA mixed solution, vortex mix thoroughly to prepare a hydrogel precursor solution, and store it at -20°C away from light.
[0034] Specifically, refer to Figure 1 , gives the actual picture of the woven bone organoid and the microscopic cell morphology in the organoid tissue. It can be seen that the woven bone organoid under this culture method still maintains a good tissue morphology as a whole, and the cells gather into balls and extend pseudopodia under the microscopic view.
[0035] Figure 2 The three-dimensional live-dead and three-dimensional cytoskeleton staining images of the cells inside the woven bone organoids in this culture method are given. It can be seen that at 21 days of induction of differentiation, the cells in the organoid tissue are well active and self-organize to form a cytoskeleton network.
[0036] Figure 3 The Micro-CT three-dimensional reconstruction of the woven bone organoids in this culture method and the scanning images of the sagittal and horizontal planes of the woven bone organoids are given. It can be seen that a large amount of minerals are produced in the woven bone organoids after 21 days of osteogenic induction culture, and they self-organize to form uniform mineralized tissues. This shows that under this culture method, the woven bone organoids have the ability to mineralize autonomously.
[0037] Figure 4 H&E and Masson staining images of paraffin sections of woven bone organoids under this culture method are given. It can be seen that after 21 days of osteogenic induction culture, the woven bone organoids showed a uniform network structure and produced collagen fibers. This shows that the woven bone organoids after 21 days of osteogenic induction have the ability to self-organize and can self-secretly produce collagen matrix.
[0038] Figure 5 The figure shows the alizarin red staining and type I collagen immunohistochemical staining of paraffin sections of woven bone organoids under this culture method. It can be seen that after 21 days of osteogenic induction culture, a large number of mineralized nodules and type I collagen began to be produced in the matrix of woven bone organoids. This shows that the woven bone organoids after 21 days of osteogenic induction began to form a mineralized network in the tissue by secreting collagen and producing mineralized nodules.
[0039] Figure 6 The immunostaining of OCN, OSX, and PDPN osteogenic-related proteins in paraffin sections of woven bone organoids under this culture method is given. It can be seen that in the woven bone organoids cultured for 21 days of osteogenic induction, OCN protein expressed by mature osteoblasts, OSX protein expressed by preosteoblasts, and PDPN protein expressed by early osteocytes coexist. This shows that cells at different developmental stages of the osteoblast lineage exist in the woven bone organoids cultured for 21 days of osteogenic induction, and it is a tissue where multiple bone cells coexist.
[0040] Embodiment 2: Reference Figures 1 to 6 This embodiment provides a method for constructing a self-organizing woven bone organoid. Based on the prepared CGDE double-network functional hydrogel, a large number of expanded BMSCs are resuspended in a hydrogel solution, and adaptive culture is performed for 5 hours after light curing. Compared with Example 1, the differences of this embodiment are: In S1-S4, the adaptive culture time of the woven bone organoids in S4 is 5 hours. Meanwhile, the osteogenic induction of the woven bone organoids in S5 is omitted.
[0041] The specific steps are as follows: S1: Preparation of CGDE double network functional hydrogel as matrix material for woven bone organoids; S2: Provide BMSCs, culture and expand them in large quantities using complete culture medium; S3: Prepare woven bone organoid matrix material. Preheat the hydrogel obtained in S1 at 37°C to make it completely solubilized. Use the preheated hydrogel solution to resuspend the cells obtained in S2. The ratio of matrix material to cells is 1 mL matrix material contains 1*10 4 ~1*10 9 After the obtained woven bone organoid precursor cell mixture is fully mixed, it is injected into a mold and irradiated under a 405nm light source for 10-60s to gel it for subsequent culture; S4: Adaptive culture of woven bone organoids: soak the samples obtained in S3 in basal culture medium, place them in a 37°C incubator for 5 hours, wash the samples, and then switch to α-MEM for adaptive culture of the organoids for 1 to 3 days; S5: Step omitted; Specifically, refer to Figure 1 , and the actual picture of the woven bone organoid and the microscopic cell morphology in the organoid tissue are given. It can be seen that the woven bone organoid under this culture method has a good overall tissue morphology, but the cells still remain independently dispersed and have no pseudopodia extension under the microscopic view, which is mainly because the cells have not yet adapted to the microscopic environment provided by the matrix material.
[0042] Figure 2 The three-dimensional live-dead and cytoskeleton staining images of the cells inside the woven bone organoids in this culture method are given. It can be seen that after 5 hours of adaptive culture, the cell activity in the organoid tissue is poor and the skeleton has not yet stretched. This is only because during this period, some cells with poor activity failed to adapt to the microenvironment provided by the matrix material, but a large number of cells with strong activity still remained in the matrix material, but this part has not yet proliferated and stretched.
[0043] Figure 3 Micro-CT three-dimensional reconstruction images of the woven bone organoids in this culture method and scanning images of the sagittal and horizontal planes of the woven bone organoids are given. It can be seen that in the initial stage of woven bone organoid culture, the organoid matrix contains a large amount of mineral components and has not been degraded in a short time.
[0044] Embodiment 3: Reference Figures 1 to 6 This embodiment provides a method for constructing a self-organizing woven bone organoid. Based on the prepared CGDE double-network functional hydrogel, a large number of expanded BMSCs are resuspended in a hydrogel solution, and adaptive culture is performed for 1 to 3 days and osteogenic induction differentiation is performed for 7 days after light curing. Compared with Example 1, the differences of this embodiment are: The osteogenic differentiation time of woven bone organoids described in S5 was 7 days.
[0045] S1: Preparation of CGDE double network functional hydrogel as matrix material for woven bone organoids; S2: Provide BMSCs, culture and expand them in large quantities using complete culture medium; S3: Prepare woven bone organoid matrix material. Preheat the hydrogel obtained in S1 at 37°C to make it completely solubilized. Use the preheated hydrogel solution to resuspend the cells obtained in S2. The ratio of matrix material to cells is 1 mL matrix material contains 1*10 4 ~1*10 9 After the obtained woven bone organoid precursor cell mixture is fully mixed, it is injected into a mold and irradiated under a 405nm light source for 10-60s to gel it for subsequent culture; S4: Adaptive culture of woven bone organoids: soak the sample obtained in S3 in basal culture medium, place it in a 37°C incubator for 5 minutes, wash the sample, and then switch to α-MEM for adaptive culture of the organoids for 1 to 3 days; S5: Osteogenic differentiation of woven bone organoids. The samples obtained in S4 were transferred to osteogenic induction medium for osteogenic induction for 7 days. Fresh medium was replaced every 1-3 days during the culture period to prepare woven bone organoids that were osteogenic differentiated for 7 days.
[0046] Specifically, refer to Figure 1 , giving the physical picture of the woven bone organoid and the microscopic cell morphology in the organoid tissue. It can be seen that the woven bone organoid under this culture method has a good tissue morphology as a whole. Under the microscopic level, the cells begin to gather into balls and gradually begin to stretch in the matrix material.
[0047] Figure 2 The three-dimensional live-dead and cytoskeleton staining images of the cells inside the woven bone organoids in this culture method are given. It can be seen that after 7 days of osteogenic induction, the initial dead cells in the organoid tissue have been degraded, but the remaining live cells have not yet shown a large number of proliferation, but the cytoskeleton has begun to stretch initially.
[0048] Figure 3 The Micro-CT three-dimensional reconstruction of the woven bone organoid under the culture method and the scanning images of the sagittal and horizontal planes of the woven bone organoid are given. It can be seen that on the 7th day of osteogenic induction differentiation of the woven bone organoid culture, compared with the mineral distribution of the adaptive culture for 5 hours in Example 2, the minerals in the matrix are reduced, which indicates that the mineral matrix has been degraded to a certain extent during the growth of the cells.
[0049] Figure 4H&E and Masson staining images of paraffin sections of woven bone organoids under this culture method are given. It can be seen that after 7 days of osteogenic induction culture, the woven bone organoids still maintain a dense matrix structure of hydrogel, and the cells aggregate into clusters and have not yet adapted well to the microenvironment provided by the matrix material.
[0050] Figure 5 Alizarin red staining and type I collagen immunohistochemical staining of paraffin sections of woven bone organoids under this culture method are given. It can be seen that compared with the organoid sections after 21 days of osteogenic induction in Example 1, no mineralized nodules and collagen matrix formation were observed in the sections after 7 days of osteogenic induction. This shows that in the first 7 days of osteogenic induction, the cells in the woven bone organoids are still in the adaptive growth stage and have not yet started osteogenic differentiation and mineralization.
[0051] Figure 6 The immunostaining of OCN, OSX, and PDPN osteogenic-related proteins in paraffin sections of woven bone organoids under this culture method is given. It can be seen that compared with Example 1, only OSX protein expressed by early osteoblasts is present in the organoid sections after 7 days of osteogenic induction. This shows that the cells in the woven bone organoids after 7 days of osteogenic induction are still in the transition stage of differentiation from stem cells to osteoblasts.
[0052] Embodiment 4: Reference Figures 1 to 6 This embodiment provides a method for constructing a self-organizing woven bone organoid. Based on the prepared CGDE double-network functional hydrogel, a large number of expanded BMSCs are resuspended in a hydrogel solution, and adaptive culture is performed for 1 to 3 days and osteogenic induction differentiation is performed for 14 days after light curing. Compared with Example 1, the differences of this embodiment are: The osteogenic differentiation time of woven bone organoids described in S5 was 14 days.
[0053] The specific steps are as follows: S1: Preparation of CGDE double network functional hydrogel as matrix material for woven bone organoids; S2: Provide BMSCs, culture and expand them in large quantities using complete culture medium; S3: Prepare woven bone organoid matrix material. Preheat the hydrogel obtained in S1 at 37°C to make it completely solubilized. Use the preheated hydrogel solution to resuspend the cells obtained in S2. The ratio of matrix material to cells is 1 mL matrix material contains 1*10 4 ~1*10 9 After the obtained woven bone organoid precursor cell mixture is fully mixed, it is injected into a mold and irradiated under a 405nm light source for 10-60s to gel it for subsequent culture; S4: Adaptive culture of woven bone organoids: soak the sample obtained in S3 in basal culture medium, place it in a 37°C incubator for 5 minutes, wash the sample, and then switch to α-MEM for adaptive culture of the organoids for 1 to 3 days; S5: osteogenic differentiation of woven bone organoids. The samples obtained in S4 were transferred to osteogenic induction medium for osteogenic induction for 14 days. Fresh medium was replaced every 1-3 days during the culture period to prepare woven bone organoids with osteogenic differentiation for 14 days. Specifically, refer to Figure 1 , gives the actual picture of the woven bone organoid and the microscopic cell morphology in the organoid tissue. It can be seen that the woven bone organoid under this culture method still maintains a good tissue morphology as a whole, and the cells begin to stretch in the matrix material to form a cell network under the microscopic view.
[0054] Figure 2 The three-dimensional live-dead and cytoskeleton staining images of the cells inside the woven bone organoids in this culture method are given. It can be seen that after 14 days of osteogenic induction, the living cells in the organoid tissue began to proliferate and grow, and formed an interconnected skeleton network.
[0055] Figure 3 The Micro-CT three-dimensional reconstruction of the woven bone organoid under the culture method and the scanning images of the sagittal and horizontal planes of the woven bone organoid are given. It can be seen that on the 14th day of osteogenic induction differentiation, compared with the mineral distribution of 7 days of osteogenic induction in Example 3, the minerals in the matrix are further reduced, indicating that the rate of mineral degradation in the organoid is still greater than the rate of mineral generation.
[0056] Figure 4 H&E and Masson staining images of paraffin sections of woven bone organoids under this culture method are given. It can be seen that after 14 days of osteogenic induction culture, the cells in the woven bone organoids began to secrete collagen matrix and degrade adjacent matrix materials, and the cells stretched and migrated in the matrix to form a cell network.
[0057] Figure 5 Alizarin red staining and type I collagen immunohistochemical staining of paraffin sections of woven bone organoids under this culture method are given. It can be seen that compared with the organoid sections at 7 days of osteogenic induction in Example 3, mineralized nodules began to appear and collagen matrix was produced in the sections at 14 days of osteogenic induction. This shows that on days 7 to 14 of osteogenic induction, the cells in the woven bone organoids gradually began to differentiate and mineralize into osteoblasts.
[0058] Figure 6The immunostaining of OCN, OSX, and PDPN osteogenic-related proteins of paraffin sections of woven bone organoids under this culture method is given. It can be seen that compared with the organoid sections in Example 3 after 7 days of osteogenic induction, the organoid sections after 14 days of osteogenic induction not only have OSX proteins expressed by early osteoblasts, but also have OCN proteins expressed by mature osteoblasts. This shows that a large number of osteoblasts have been produced in the woven bone organoids after 14 days of osteogenic induction, but have not yet differentiated into osteocytes.
[0059] Embodiment 5: Reference Figures 1 to 6 This embodiment provides a method for constructing a self-organizing woven bone organoid. Based on the prepared CGDE double network functional hydrogel, a large number of expanded BMSCs are resuspended in a hydrogel solution, and adaptive culture is performed for 1 to 3 days and osteogenic induction differentiation is performed for 30 days after light curing. Compared with Example 1, the differences of this embodiment are: The osteogenic differentiation time of woven bone organoids described in S5 was 30 days.
[0060] The specific steps are as follows: S1: Preparation of CGDE double network functional hydrogel as matrix material for woven bone organoids; S2: Provide BMSCs, culture and expand them in large quantities using complete culture medium; S3: Prepare woven bone organoid matrix material. Preheat the hydrogel obtained in S1 at 37°C to make it completely solubilized. Use the preheated hydrogel solution to resuspend the cells obtained in S2. The ratio of matrix material to cells is 1 mL matrix material contains 1*10 4 ~1*10 9 After the obtained woven bone organoid precursor cell mixture is fully mixed, it is injected into a mold and irradiated under a 405nm light source for 10-60s to gel it for subsequent culture; S4: Adaptive culture of woven bone organoids: soak the sample obtained in S3 in basal culture medium, place it in a 37°C incubator for 5 minutes, wash the sample, and then switch to α-MEM for adaptive culture of the organoids for 1 to 3 days; S5: osteogenic differentiation of woven bone organoids. The samples obtained in S4 were transferred to osteogenic induction medium for osteogenic induction for 30 days. During the culture period, fresh medium was replaced every 1-3 days to prepare woven bone organoids with osteogenic differentiation for 30 days. Specifically, refer to Figure 1 , and the actual picture of the woven bone organoid and the microscopic cell morphology in the organoid tissue are given. It can be seen that the overall structure of the woven bone organoid under this culture method tends to collapse and degrade. Under the microscopic view, the cells shrink and gather together, and the extension of pseudopodia is significantly weakened.
[0061] Figure 2 The three-dimensional live-dead and cytoskeleton staining images of the cells inside the woven bone organoids in this culture method are given. It can be seen that after 30 days of osteogenic induction, dead cells began to appear in the organoid tissue, the number of live cells also decreased significantly, and the cytoskeleton network weakened, which may be attributed to the large amount of metabolites in the matrix material affecting cell activity.
[0062] Figure 3 The Micro-CT three-dimensional reconstruction of the woven bone organoid under the culture method and the scanning images of the sagittal and horizontal planes of the woven bone organoid are given. It can be seen that compared with the mineral content of osteogenic induction for 21 days in Example 1, the minerals in the organoid tissue increased further on the 30th day of osteogenic induction differentiation, which indicates that the cell mineral deposition rate in the organoid during the 21-30 days of induction differentiation is still faster than the matrix mineral degradation rate.
[0063] Figure 4 H&E and Masson staining images of paraffin sections of woven bone organoids under this culture method are given. It can be seen that after 30 days of osteogenic induction culture, the network structure formed by the self-organization of cells in the woven bone organoids began to collapse, and the osteocytes had reached the end of differentiation, matured and aged, and began to disintegrate.
[0064] Figure 5 The alizarin red staining and type I collagen immunohistochemical staining of paraffin sections of woven bone organoids under this culture method are given. It can be seen that compared with the organoid sections after 21 days of osteogenic induction in Example 1, the matrix in the sections after 30 days of osteogenic induction has been completely mineralized from the outside to the inside, and a large amount of collagen matrix is generated. This shows that at 30 days of osteogenic induction, the cells in the woven bone organoids have been completely differentiated and mineralized.
[0065] Figure 6 The immunostaining of OCN, OSX, and PDPN osteogenic-related proteins of paraffin sections of woven bone organoids under the culture method is given. It can be seen that compared with the organoid sections in Example 1 after 21 days of osteogenic induction, the organoid sections after 30 days of osteogenic induction contain OCN protein expressed by mature osteoblasts.
[0066] Embodiment 6: This example is an application of woven bone organoids prepared by the preparation methods described in Examples 1, 3, 4, and 5 in bone defect repair.
[0067] (1) Skull defect modeling: 4-6 week-old healthy male Sprague-Dawley rats were selected and anesthetized using a small animal anesthesia machine. The gas flow rate was set to 500 mL / min. During induction of anesthesia, the concentration of inhaled anesthetic isoflurane was 4%, and during maintenance of anesthesia, the concentration of isoflurane was 2-3%. After the rats were fully anesthetized, the skin was prepared, disinfected, and draped. A longitudinal surgical incision of 1.5-3 cm long was made along the sagittal line of the skull to separate the soft tissue layer by layer, and the periosteum was fully peeled off. A round drill was used to make two 5 mm diameter bone defects on both sides of the sagittal line, and the wound was rinsed with saline.
[0068] (2) Material implantation and animal sampling: After modeling, woven bone organoids with a diameter of 5 mm and a thickness of 2 mm were implanted at different time sequences at the bone defect site, including the woven bone organoids in Example 1 that were induced for 21 days of osteogenic induction, and the woven bone organoids in Examples 3 to 5 that were induced for 7, 14, and 30 days of osteogenic induction, respectively. Each group of organoids was transplanted into the bone defect sites of 6 different rats, and the skin was sutured and the wound was disinfected after implantation. The rats in each group were sampled and analyzed at 4 and 12 weeks of treatment.
[0069] Figure 7 Micro-CT three-dimensional reconstruction images of the rat skull defect after implantation of woven bone organoids of different time sequences and scanning images of the sagittal and horizontal planes are given. The results show that after 21 days of osteogenic induction, the woven bone organoids showed excellent bone repair activity, which can effectively promote new bone formation at the defect site at 4 weeks, and can effectively integrate with native bone tissue after 12 weeks. In addition, the bone repair activity of woven bone organoids with osteogenic induction for 7 to 21 days increases with the increase of induction time, but the bone repair activity of woven bone organoids with osteogenic induction for 30 days is significantly reduced compared with the woven bone organoids with osteogenic induction for 21 days, which is similar to the repair activity of woven bone organoids with induced differentiation for 7 days. This shows that osteogenic induction for too long will reduce the activity of organoids and thus affect their repair effect. Compared with the CGDE group of Comparative Example 2, it can be seen that the repair activity of woven bone organoids with different time sequences is stronger than that of the simple matrix material group, which shows that the loading of cells in the material can effectively enhance its bone repair activity. In addition, compared with the Con group of Comparative Example 1, the remaining groups have a certain degree of bone repair effect.
[0070] Example 7 (Comparative Example 1 in Example 6) (1) Same as Example 6 (1).
[0071] (2) Animal sampling: After modeling, rats in the blank control (Con) group were not implanted with any materials. Their skin was directly sutured and the wound was disinfected. Samples were collected and analyzed at 4 and 12 weeks of treatment.
[0072] Figure 7It can be seen that compared with the CGDE group of Comparative Example 2 and Examples 1, 3, 4, and 5, the Con group of Comparative Example 1 had no obvious new bone formation at 4 weeks and 12 weeks, which proves that the animal modeling formed a critical bone defect that could not be healed by the animal's self-repair ability.
[0073] Example 8 (for Comparative Example 2 in Example 6): (1) Same as Example 6 (1).
[0074] (2) Material implantation and animal sampling: After modeling, rats in the simple matrix material (CGDE) group were implanted with a 5 mm diameter and 2 mm thick light-cured CGDE hydrogel prepared by S1 at the bone defect site. After implantation, the skin was sutured and the wound was disinfected. Samples were collected and analyzed at 4 and 12 weeks of treatment.
[0075] Figure 7 It can be seen that compared with Examples 1, 3, 4, and 5, the CGDE group of Comparative Example 2 had limited new bone formation and slow bone repair at 4 and 12 weeks, which proves that the bone repair activity of woven bone organoids is mainly attributed to the cells loaded therein.
[0076] The above is only a specific implementation of the present application, but the protection scope of the present application is not limited thereto. Any technician familiar with the technical field can easily think of various equivalent modifications or replacements within the technical scope disclosed in the present application, and these modifications or replacements should be included in the protection scope of the present application. Therefore, the protection scope of the present application shall be based on the protection scope of the claims.
Claims
1. A method for constructing a self-organizing woven bone organoid, characterized in that: The following steps are involved: S1: Preparation of CGDE double network functional hydrogel as matrix material for woven bone organoids; S2: Provide woven bone organoid seed cells, culture and expand them in large quantities using complete culture medium; S3: Prepare woven bone organoid bio-ink, preheat the matrix material obtained in S1 at 37°C to completely solubilize it, use the preheated matrix material solution to resuspend the cells obtained in S2, mix thoroughly, inject into the mold and irradiate under a 405nm light source for 10-60s to gel it for subsequent culture; S4: Adaptive culture of woven bone organoids. Soak the sample obtained in S3 in basal culture medium and place it in a 37°C incubator for 5 minutes. Wash the sample and then use complete culture medium to adaptively culture the organoids for 1-7 days. During the culture period, use fresh culture medium every 2-3 days. S5: Osteogenic differentiation of woven bone organoids. The samples obtained in S4 were transferred to osteogenic induction medium for osteogenic induction for 7-40 days. Fresh medium was replaced every 2-3 days during the culture period to prepare woven bone organoids at different developmental stages.
2. A method for constructing a self-organizing woven bone organoid according to claim 1, characterized in that: The CGDE double network functional hydrogel described in S1 is formed by a complex of catalase, GelMa, energy-active calcium phosphate, and DNA; the preparation method of the CGDE double network functional hydrogel is as follows: S11: Prepare CAT solution by dissolving 100-400 mg CAT, 10-50 mg AC-PEG-NHS crosslinker, and 10-100 mg LAP photoinitiator in 20 mL PBS, vortex for 5 minutes in the dark, filter through a 0.22 μm filter membrane to sterilize, and incubate at 4 °C in the dark for 18-24 h; S12: Prepare GelMa solution by soaking 1 g of GelMa in 5-20 mL of PBS, heating and dissolving at 60-70°C for 0.5-2 hours, filtering and sterilizing with a 0.22 μm filter membrane to prepare GelMa solution, and storing at -20°C; S13: Prepare EACP nanoparticles. Add 25 mL of an aqueous solution containing 1-5 g Na2ATP to 900 mL of pure water, then add 20 mL of an aqueous solution containing 0.5-3 g CaCl2, mix thoroughly, adjust the pH to 8.0-8.5 with 0.2 M NaOH, and then add 1.6 mL of an aqueous solution containing 1.5-6 mg ALP to react for 2-6 hours. During the reaction, the pH is maintained at 8.0-8.
5. After the reaction is completed, centrifuge to obtain EACP nanoparticles, wash the precipitate with pure water 2-3 times, then soak in anhydrous ethanol, and store at -20°C; S14: Prepare a DNA mixed solution, add DEPC water to Y-1, Y-2, Y-3, L-1, and L-2, vortex and dissolve to prepare a 50-200 μM DNA solution, mix Y-1, Y-2, and Y-3 in equal proportions to prepare a Y-DNA mixed solution, mix L-1 and L-2 in equal proportions to prepare an L-DNA mixed solution, and store at -20°C; S15: Mix the CAT solution obtained in S11 and the GelMa solution obtained in S12 in a mass ratio of 1:1, add the EACP obtained in S13, the Y-DNA mixed solution obtained in S14 and the L-DNA mixed solution, vortex mix thoroughly to prepare a hydrogel precursor solution, and store it at -20°C away from light.
3. The method for constructing a self-organizing woven bone organoid according to claim 1, characterized in that: The seed cell types described in S2 include bone cell lineages such as BMSC, MC3T3-E1, PDCs, and Osteoblast.
4. A method for constructing a self-organizing woven bone organoid according to claim 1, characterized in that In the woven bone organoid bio-ink described in S3, the ratio of matrix material solution to cells contained 1*10 4 ~1*10 9 cells.
5. The method for constructing a self-organizing woven bone organoid according to claim 1, characterized in that The preparation method of the complete medium for organoid adaptive culture described in S4 is to add 50 mL of FBS and 5 mL of PS into 500 mL of basal culture medium; the basal culture medium used includes but is not limited to α, DMEM, and DMEM / F-12.
6. The method for constructing a self-organizing woven bone organoid according to claim 1, characterized in that: The preparation method of the osteogenic differentiation medium described in S5 is to add 50 mL FBS, 5 mL PS, 5 mL 1M β-GP, 1.25 mL 20 mg / mL Vitamin C, and 50 μL 100 μM Dex into 500 mL DMEM medium.
7. A self-organizing woven bone organoid, characterized in that: The self-organizing woven bone organoid is prepared by the method for constructing the self-organizing woven bone organoid according to any one of claims 1 to 6.
8. Use of the self-organizing woven bone organoids described in claim 7 in bone physiology and pathology research and bone regeneration and repair.
9. The use according to claim 8, wherein the woven bone organoid is used as an implant, transplanted into the bone defect site, and effectively integrated with the bone tissue after reconstruction to achieve bone regeneration and repair.
Citation Information
Cited By
Bone organ for promoting nerve ingrowth and construction method and application thereof
CN120866213A
A nerve growth-promoting bone organoid and a construction method and application thereof
CN120866213B
Preparation method and application of bone organ
CN120888493A
Pathological sugar bone organoid and construction method and application thereof
CN123083740A
